Abstract
Post-ERCP pancreatitis (PEP) is a potential complication of ERCP. Pharmacotherapy for prevention of PEP aims at reducing basal sphincter pressure and contractility or a decrease in pancreatic secretion to reduce intraductal pressure. Timing and route of administration of drugs are critical to ensure maximum benefits from medications. Pancreatic stenting offers an alternative to decompress the pancreas and is effective in reducing PEP in high-risk patients.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 52-55 |
| Number of pages | 4 |
| Journal | American Journal of Gastroenterology |
| Volume | 102 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2007 |
Fingerprint
ASJC Scopus subject areas
- Gastroenterology
Cite this
Pharmacotherapy for the prevention of post-ERCP pancreatitis. / Foster, Erina; Leung, Joseph.
In: American Journal of Gastroenterology, Vol. 102, No. 1, 01.2007, p. 52-55.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Pharmacotherapy for the prevention of post-ERCP pancreatitis
AU - Foster, Erina
AU - Leung, Joseph
PY - 2007/1
Y1 - 2007/1
N2 - Post-ERCP pancreatitis (PEP) is a potential complication of ERCP. Pharmacotherapy for prevention of PEP aims at reducing basal sphincter pressure and contractility or a decrease in pancreatic secretion to reduce intraductal pressure. Timing and route of administration of drugs are critical to ensure maximum benefits from medications. Pancreatic stenting offers an alternative to decompress the pancreas and is effective in reducing PEP in high-risk patients.
AB - Post-ERCP pancreatitis (PEP) is a potential complication of ERCP. Pharmacotherapy for prevention of PEP aims at reducing basal sphincter pressure and contractility or a decrease in pancreatic secretion to reduce intraductal pressure. Timing and route of administration of drugs are critical to ensure maximum benefits from medications. Pancreatic stenting offers an alternative to decompress the pancreas and is effective in reducing PEP in high-risk patients.
UR - http://www.scopus.com/inward/record.url?scp=33846063359&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33846063359&partnerID=8YFLogxK
U2 - 10.1111/j.1572-0241.2006.00950.x
DO - 10.1111/j.1572-0241.2006.00950.x
M3 - Article
C2 - 17266688
AN - SCOPUS:33846063359
VL - 102
SP - 52
EP - 55
JO - American Journal of Gastroenterology
JF - American Journal of Gastroenterology
SN - 0002-9270
IS - 1
ER -